Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Boehringer Ingelheim exercises IP options to support development of gene therapy for cystic fibrosis

Oct. 19, 2021

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

Oct. 8, 2021

Blade reports preclinical drug-drug interaction data on cudetaxestat for IPF

Sep. 21, 2021

SCN-16 targets the Keap1-Nrf2 protective pathway to treat ALI

Sep. 16, 2021

EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo

Sep. 15, 2021

PRS-220 shows favorable PK and biodistribution in fibrotic lung models

Sep. 13, 2021

GRC-39815 shows efficacy in models of smoke-induced COPD

Sep. 10, 2021

OR2AT4 identified as a new therapeutic target in COPD

Sep. 8, 2021

AI-driven discovery of novel candidates for idiopathic pulmonary fibrosis

Sep. 7, 2021

BI-1265162, an inhaled ENaC inhibitor for the mutation-agnostic treatment of cystic fibrosis

Sep. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...